http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3795582-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76195fd1cd08192222699d8e7a88c231
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
filingDate 1973-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1974-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bb367928b8c392bc30a580493fa9555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e72ee53a459db9b2f7000b3ebc532a
publicationDate 1974-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3795582-A
titleOfInvention Inhibition of aggregation of blood platelets
abstract THE ACTIVITY OF PGE1 IN INHIBITING AGGREGATION OF BLOOD PLATELETS IS ENHANCED BY EMPLOYING THE PGE1 IN COMBINATION WITH 1-ETHYL-4-ISOPROPYLIDENEHYDRAZINO-1H-PYRAZOLO(3,4-B)PYRIDINE-5-CARBOXYLIC ACID, ETHYL ESTER.
priorityDate 1973-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428438116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21823918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432212879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154220260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420218183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71586773

Total number of triples: 21.